skip to main content
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
General and dedicated cancer emergency room: Clinical and financial implications
Material Type:
Artigo
Adicionar ao Meu Espaço

General and dedicated cancer emergency room: Clinical and financial implications

Malavasi, N. ; Fiorani, C. ; Ferrara, L. ; Postiglione, R. ; Scarabelli, L. ; Cantile, F. ; Saviola, A. ; Longo, G. ; Luciani, A. ; Cascinu, S.

Annals of oncology, 2018-10, Vol.29, p.viii623-viii623 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

2
A novel electronic tool to implement palliative sedation (PS) in a department of oncologic medicine
Material Type:
Artigo
Adicionar ao Meu Espaço

A novel electronic tool to implement palliative sedation (PS) in a department of oncologic medicine

Saviola, A. ; Cascinu, S. ; Salati, M. ; Longo, G. ; Fiorani, C. ; Ferrara, L. ; Malavasi, N. ; Postiglione, R. ; Cantile, F. ; Scarabelli, L. ; Rimini, M. ; Ferri, F.

Annals of oncology, 2018-10, Vol.29, p.viii554-viii554 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

3
blockade overcomes primary and acquired resistance to anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer (mCRC)
Material Type:
Artigo
Adicionar ao Meu Espaço

blockade overcomes primary and acquired resistance to anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer (mCRC)

Martini, G. ; Belli, V. ; Vitiello, P.P. ; Troiani, T. ; Cardone, C. ; Napolitano, S. ; Desiderio, V. ; Sforza, V. ; Ferrara, M.L. ; Papaccio, G. ; Mele, L. ; Liguori, G. ; Botti, G. ; Franco, R. ; Morgillo, F. ; Ciardiello, F. ; Martinelli, E.

Annals of oncology, 2016-10, Vol.27, p.vi1-vi1 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

4
HER2 activation and epithelial-mesenchymal transition (EMT) are involved in the acquired resistance to cetuximab in combination with either regorafenib or refametinib
Material Type:
Artigo
Adicionar ao Meu Espaço

HER2 activation and epithelial-mesenchymal transition (EMT) are involved in the acquired resistance to cetuximab in combination with either regorafenib or refametinib

Vitiello, P.P. ; Martini, G. ; Belli, V. ; Cardone, C. ; Sforza, V. ; Ferrara, M.L. ; Napolitano, S. ; Della Corte, C.M. ; Zanaletti, N. ; Vitale, P. ; Pompella, L. ; Morgillo, F. ; Troiani, T. ; Ciardiello, F. ; Martinelli, E.

Annals of oncology, 2016-10, Vol.27, p.vi4-vi4 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

5
AXL activation can promote resistance to MEK inhibition in a model of colorectal cancer (CRC)
Material Type:
Artigo
Adicionar ao Meu Espaço

AXL activation can promote resistance to MEK inhibition in a model of colorectal cancer (CRC)

Martini, G. ; Belli, V. ; Vitiello, P.P. ; Troiani, T. ; Cardone, C. ; Napolitano, S. ; Sforza, V. ; Ferrara, M.L. ; Morgillo, F. ; Ciardiello, D. ; Giunta, E.F. ; Ciardiello, F. ; Martinelli, E.

Annals of oncology, 2016-10, Vol.27, p.vi8-vi8 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

6
Transforming growth factor beta receptor (TGF&bgr;R) pathway is involved in ligand independent transactivation of AXL receptor in colorectal cancer (CRC) cell lines
Material Type:
Artigo
Adicionar ao Meu Espaço

Transforming growth factor beta receptor (TGF&bgr;R) pathway is involved in ligand independent transactivation of AXL receptor in colorectal cancer (CRC) cell lines

Franzese, E. ; Martini, G. ; Cardone, C. ; Troiani, T. ; Sforza, V. ; Ferrara, M.L. ; Belli, V. ; Vitiello, P.P. ; Napolitano, S. ; Zanaletti, N. ; Vitale, P. ; De Vita, F. ; Orditura, M. ; Morgillo, F. ; Ciardiello, F. ; Martinelli, E.

Annals of oncology, 2016-10, Vol.27, p.vi8-vi8 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

7
1745PGeneral and dedicated cancer emergency room: Clinical and financial implications
Material Type:
Artigo
Adicionar ao Meu Espaço

1745PGeneral and dedicated cancer emergency room: Clinical and financial implications

Malavasi, N ; Fiorani, C ; Ferrara, L ; Postiglione, R ; Scarabelli, L ; Cantile, F ; Saviola, A ; Longo, G ; Luciani, A ; Cascinu, S

Annals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

8
1533PA novel electronic tool to implement palliative sedation (PS) in a department of oncologic medicine
Material Type:
Artigo
Adicionar ao Meu Espaço

1533PA novel electronic tool to implement palliative sedation (PS) in a department of oncologic medicine

Saviola, A ; Cascinu, S ; Salati, M ; Longo, G ; Fiorani, C ; Ferrara, L ; Malavasi, N ; Postiglione, R ; Cantile, F ; Scarabelli, L ; Rimini, M ; Ferri, F

Annals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

9
Immunosenescence (iSenescence) correlates with disease progression in advanced non-small cell lung cancer (aNSCLC) patients treated with PD-(L)1 inhibitors (IO)
Material Type:
Artigo
Adicionar ao Meu Espaço

Immunosenescence (iSenescence) correlates with disease progression in advanced non-small cell lung cancer (aNSCLC) patients treated with PD-(L)1 inhibitors (IO)

Ferrara, R. ; Naigeon, M. ; Auclin, E. ; Duchemann, B. ; Cassard, L. ; Medhi, J. ; Boselli, L. ; Grivel, J. ; Desnoyer, A. ; Mezquita, L. ; Aboubakar, F. ; Hendriks, L. ; Planchard, D. ; Caramella, C. ; Remon, J. ; Ngocamus, M. ; Nicotra, C. ; Besse, B. ; Chaput, N.

Annals of oncology, 2018-10, Vol.29, p.viii511-viii511 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

10
Immunosenescence (iSenescence) correlates with progression (PD) to PD-(L)1 inhibitors (IO) and not to platinum-chemotherapy (PCT) in advanced non-small cell lung cancer (aNSCLC) patients (pts)
Material Type:
Artigo
Adicionar ao Meu Espaço

Immunosenescence (iSenescence) correlates with progression (PD) to PD-(L)1 inhibitors (IO) and not to platinum-chemotherapy (PCT) in advanced non-small cell lung cancer (aNSCLC) patients (pts)

Ferrara, R. ; Naigeon, M. ; Auclin, E. ; Duchemann, B. ; Cassard, L. ; Medhi, J.J. ; Boselli, L. ; Grivel, J. ; Desnoyer, A. ; Mezquita, L. ; Hendriks, L. ; Planchard, D. ; Caramella, C. ; Remon-Masip, J. ; Sangaletti, S. ; Garassino, M.C. ; Besse, B. ; Chaput, N.

Annals of oncology, 2019-04, Vol.30, p.ii7-ii8 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Buscando em bases de dados remotas. Favor aguardar.